Drugs that contain Secnidazole

1. List of Solosec drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10335390 LUPIN Secnidazole for use in the treatment of bacterial vaginosis
Sep, 2035

(12 years from now)

US11000507 LUPIN Secnidazole for use in the treatment of bacterial vaginosis
Sep, 2035

(12 years from now)

US11020377 LUPIN Secnidazole for use in the treatment of bacterial vaginosis
Sep, 2035

(12 years from now)

US11000508 LUPIN Secnidazole for use in the treatment of trichomoniasis
Sep, 2035

(12 years from now)

US10682338 LUPIN Secnidazole for use in the treatment of bacterial vaginosis
Sep, 2035

(12 years from now)

US10849884 LUPIN Secnidazole for use in the treatment of bacterial vaginosis
Sep, 2035

(12 years from now)

US10857133 LUPIN Secnidazole for use in the treatment of bacterial vaginosis
Sep, 2035

(12 years from now)

US11324721 LUPIN Secnidazole for use in the treatment of trichomoniasis
Sep, 2035

(12 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Sep 15, 2022
New Indication (I) Jun 30, 2024
New Patient Population (NPP) Jan 26, 2025
Generating Antibiotic Incentives Now (GAIN) Sep 15, 2027

NCE-1 date: September, 2026

Market Authorisation Date: 15 September, 2017

Treatment: Treatment of bacterial vaginosis in adult women; Treatment of bacterial vaginosis in female patients 12 years of age and older; Treatment of trichomoniasis in patients 12 years of age and older; Treatment of trichomoniasis in adults

Dosage: GRANULE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in